Date: 19.06.2026

QIP Allotment Details

The Finance & Investment Committee at its meeting held on June 19, 2026 approved allotment of 1,98,67,549 Equity Shares of face value ₹ 2 each to eligible qualified institutional buyers at the issue price of ₹ 755 per Equity Share, which includes a premium of ₹ 753 per Equity Share. The issue price reflects a discount of ₹ 16.73 (2.17% of the floor price) to the floor price of ₹ 771.73 per Equity Share. The total amount raised aggregates to approximately ₹ 15,000 million.

Capital Structure Change

Pursuant to the allotment, the paid-up equity share capital of the Company increased from ₹ 80,02,77,870 consisting of 40,01,38,935 Equity Shares to ₹ 84,00,12,968 consisting of 42,00,06,484 Equity Shares.

Issue Timeline

The QIP opened on June 16, 2026 and closed on June 19, 2026.

Major Allottees (Over 5% of Issue)

  • International Finance Corporation: 19,86,755 shares (10.00%)
  • SBI ELSS Tax Saver Fund: 13,24,503 shares (6.67%)
  • SBI Healthcare Opportunities Fund: 3,31,126 shares (1.67%)
  • HDFC Life Insurance Company Limited: 13,24,503 shares (6.67%)
  • Kotak Flexicap Fund: 10,73,921 shares (5.41%)
  • Nippon India Small Cap Fund: 9,93,377 shares (5.00%)
  • Axis ELSS Tax Saver Fund: 10,18,849 shares (5.13%)
  • Polar Capital Funds PLC - Healthcare Opportunities Fund: 13,21,996 shares (6.65%)
  • ICICI Prudential Smallcap Fund: 10,26,490 shares (5.17%)
  • Kotak Mahindra Life Insurance Company Ltd.: 10,26,490 shares (5.17%)
  • Invesco India Smallcap Fund: 10,26,490 shares (5.17%)

Regulatory Framework

The QIP was conducted under Chapter VI of the SEBI ICDR Regulations and Sections 42 and 62(1)(c) of the Companies Act, 2013. The allotment was authorized by the board of directors on March 11, 2026 and shareholders via postal ballot on April 15, 2026.

Share Characteristics

The allotted Equity Shares shall rank pari passu with the existing Equity Shares of the Company and be entitled to dividends and corporate benefits declared after the allotment.

Authorized Personnel

Dr. Bhaskar Rao Bollineni (Managing Director), Sachin Ashok Salvi (Chief Financial Officer), and Mrs. Nagajayanthi JR (Company Secretary) were authorized to complete all necessary formalities including filing return of allotment in e-form PAS-3 with ROC, Telangana, filing FC-GPR with RBI, payment of stamp duty, and obtaining final listing approvals from NSE and BSE.

Committee Meeting Details

The Finance & Investment Committee meeting commenced at 10:30 p.m. and concluded at 11:35 p.m. on June 19, 2026 at 4th Floor, Block III, KIMS Hospital, Secunderabad.